Dr. Jeffrey M. Kaplan, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 39
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 204
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
KS license 0430445
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Shawnee Mission Shawnee Mission, KS
- Adventhealth South Overland PArk, Inc Overland PArk, KS
Medical groups
- Shawnee Mission Medical Center Inc (286 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 204
- Services billed
- 74,053
- Patients’ average age
- 68
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 37,708 | 61 |
| Injection, eptinezumab-jjmr, 1 mg | 8,000 | 18 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 150 | 50 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 148 | 35 |
| Established patient office or other outpatient visit, 40-54 minutes | 136 | 90 |
| Injection of additional new drug or substance into vein | 76 | 16 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 66 | 40 |
| Injection, ketorolac tromethamine, per 15 mg | 65 | 13 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 30 | 11 |
| Sleep study including heart rate, breathing, airflow, and effort | 25 | 25 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 28 companies reported 299 payments worth $213,233 in total to this clinician.
| EMD Serono, Inc. | $129,827 |
|---|---|
| AbbVie Inc. | $18,608 |
| Biogen, Inc. | $17,856 |
| Vanda Pharmaceuticals Inc. | $16,118 |
| Tg Therapeutics, Inc. | $10,135 |
| Amgen Inc. | $8,678 |
| Mallinckrodt Hospital Products Inc. | $6,382 |
| Lundbeck LLC | $4,516 |
| Compensation for services other than consulting (speaking, faculty) | $173,147 |
|---|---|
| Travel and Lodging | $26,969 |
| Food and Beverage | $5,582 |
| Honoraria | $4,375 |
| Consulting Fee | $2,825 |
| Education | $335 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| EMD Serono, Inc. May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $10,438 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $7,933 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $6,263 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $6,263 |
| AbbVie Inc. May 2, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $5,200 |
| AbbVie Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $5,200 |
All 88 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| EMD Serono, Inc. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $835 |
| Teva Pharmaceuticals USA, Inc. Dec 17, 2025 | Education in-kind | $95.49 |
| Lundbeck LLC Dec 11, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,000 |
| Biogen, Inc. Nov 21, 2025 | Consulting Fee TYSABRI · Neurology | $1,883 |
| AbbVie Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA; UBRELVY · NEUROSCIENCE | $3,250 |
| Tg Therapeutics, Inc. Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,713 |
| Tg Therapeutics, Inc. Nov 12, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Kansas City, MO · in-kind | $716 |
| Tg Therapeutics, Inc. Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $465 |
| EMD Serono, Inc. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $2,088 |
| Mallinckrodt Hospital Products Inc. Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $3,150 |
| Biogen, Inc. Oct 21, 2025 | Education in-kind | $63.00 |
| Mallinckrodt Hospital Products Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $3,150 |
| EMD Serono, Inc. Oct 1, 2025 | Education in-kind Company’s descriptionReprints | $55.50 |
| AbbVie Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $5,200 |
| Biogen, Inc. Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $1,614 |
| Tg Therapeutics, Inc. Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $233 |
| Vanda Pharmaceuticals Inc. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) PONVORY · MULTIPLE SCLEROSIS | $3,450 |
| Vanda Pharmaceuticals Inc. Sep 10, 2025 | Travel and Lodging PONVORY · MULTIPLE SCLEROSIS · travel to KANSAS CITY, MO | $10.50 |
| EMD Serono, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $2,088 |
| Amgen Inc. Sep 3, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,450 |
| EMD Serono, Inc. Aug 25, 2025 | Education in-kind Company’s descriptionReprints | $55.50 |
| EMD Serono, Inc. Aug 25, 2025 | Education in-kind Company’s descriptionReprints | $55.50 |
| Vanda Pharmaceuticals Inc. Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) PONVORY · MULTIPLE SCLEROSIS | $2,875 |
| Vanda Pharmaceuticals Inc. Aug 20, 2025 | Travel and Lodging PONVORY · MULTIPLE SCLEROSIS · travel to KANSAS CITY, KS | $291 |
| Vanda Pharmaceuticals Inc. Aug 13, 2025 | Compensation for services other than consulting (speaking, faculty) PONVORY · MULTIPLE SCLEROSIS | $2,875 |
| Biogen, Inc. Aug 11, 2025 | Consulting Fee TYSABRI · Neurology | $269 |
| Biogen, Inc. Aug 4, 2025 | Consulting Fee VUMERITY · Neurology | $538 |
| EMD Serono, Inc. May 22, 2025 | Education in-kind Company’s descriptionReprints | $9.64 |
| Biogen, Inc. May 21, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $1,614 |
| EMD Serono, Inc. May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $10,438 |
| Biogen, Inc. May 14, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $3,228 |
| Tg Therapeutics, Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,713 |
| Tg Therapeutics, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $1,163 |
| AbbVie Inc. May 2, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $5,200 |
| AbbVie Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $3,413 |
| Amgen Inc. Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,450 |
| Amgen Inc. Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $575 |
| Amgen Inc. Apr 25, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to SPRINGFIELD, MO · in-kind | $890 |
| Vanda Pharmaceuticals Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) PONVORY · MULTIPLE SCLEROSIS | $2,875 |
| Vanda Pharmaceuticals Inc. Apr 9, 2025 | Travel and Lodging PONVORY · MULTIPLE SCLEROSIS · travel to NORTH KANSAS CITY, MO | $433 |
| EMD Serono, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $4,593 |
| EMD Serono, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $4,593 |
| EMD Serono, Inc. Apr 4, 2025 | Travel and Lodging travel to Dallas, TX Company’s descriptionSpeaking Services (Lodging) | $319 |
| EMD Serono, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $7,933 |
| Biogen, Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) VUMERITY · Neurology | $3,228 |
| AbbVie Inc. Mar 29, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to DALLAS, TX · in-kind | $576 |
| AbbVie Inc. Mar 29, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to DALLAS, TX · in-kind | $327 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $6,263 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $6,263 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $4,593 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $4,593 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $4,593 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $2,923 |
| EMD Serono, Inc. Mar 20, 2025 | Travel and Lodging Mavenclad · Neurology · travel to San Juan, PR Company’s descriptionSpeaking Services (Transportation) | $1,347 |
| EMD Serono, Inc. Mar 20, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Caguas, PR Company’s descriptionSpeaking Services (Transportation) | $1,199 |
| EMD Serono, Inc. Mar 20, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Caguas, PR Company’s descriptionSpeaking Services (Lodging) | $891 |
| EMD Serono, Inc. Mar 19, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Homewood, AL Company’s descriptionSpeaking Services (Transportation) | $350 |
| EMD Serono, Inc. Mar 18, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Cullman, AL Company’s descriptionSpeaking Services (Transportation) | $4,756 |
| EMD Serono, Inc. Mar 18, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Cullman, AL Company’s descriptionSpeaking Services (Transportation) | $794 |
| EMD Serono, Inc. Mar 18, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Cullman, AL Company’s descriptionSpeaking Services (Lodging) | $237 |
| EMD Serono, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $9,603 |
| EMD Serono, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $2,923 |
| EMD Serono, Inc. Mar 13, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Dallas, TX Company’s descriptionSpeaking Services (Transportation) | $1,188 |
| EMD Serono, Inc. Mar 13, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Dallas, TX Company’s descriptionSpeaking Services (Transportation) | $909 |
| EMD Serono, Inc. Mar 13, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Sherman, TX Company’s descriptionSpeaking Services (Transportation) | $688 |
| EMD Serono, Inc. Mar 13, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Dallas, TX Company’s descriptionSpeaking Services (Lodging) | $309 |
| Biogen, Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $1,614 |
| Lundbeck LLC Mar 11, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,375 |
| EMD Serono, Inc. Mar 7, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Raleigh, NC Company’s descriptionSpeaking Services (Transportation) | $1,469 |
| EMD Serono, Inc. Mar 7, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Raleigh, NC Company’s descriptionSpeaking Services (Transportation) | $962 |
| EMD Serono, Inc. Mar 6, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Charlotte, NC Company’s descriptionSpeaking Services (Transportation) | $1,443 |
| EMD Serono, Inc. Mar 6, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Mooresville, NC Company’s descriptionSpeaking Services (Transportation) | $228 |
| EMD Serono, Inc. Mar 5, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Winston Salem, NC Company’s descriptionSpeaking Services (Transportation) | $1,245 |
| EMD Serono, Inc. Mar 5, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Winston Salem, NC Company’s descriptionSpeaking Services (Transportation) | $1,142 |
| EMD Serono, Inc. Mar 5, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Charlotte, NC Company’s descriptionSpeaking Services (Lodging) | $724 |
| EMD Serono, Inc. Mar 5, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Charlotte, NC Company’s descriptionSpeaking Services (Transportation) | $537 |
| Biogen, Inc. Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $3,228 |
| EMD Serono, Inc. Feb 25, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Tampa, FL Company’s descriptionSpeaking Services (Transportation) | $1,562 |
| EMD Serono, Inc. Feb 25, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Tampa, FL Company’s descriptionSpeaking Services (Lodging) | $608 |
| EMD Serono, Inc. Feb 25, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Tampa, FL Company’s descriptionSpeaking Services (Transportation) | $418 |
| EMD Serono, Inc. Feb 25, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Tampa, FL Company’s descriptionSpeaking Services (Transportation) | $360 |
| Vanda Pharmaceuticals Inc. Feb 12, 2025 | Compensation for services other than consulting (speaking, faculty) PONVORY · MULTIPLE SCLEROSIS | $2,875 |
| Vanda Pharmaceuticals Inc. Feb 12, 2025 | Travel and Lodging PONVORY · MULTIPLE SCLEROSIS · travel to KANSAS CITY, MO | $40.00 |
| EMD Serono, Inc. Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $418 |
| Biogen, Inc. Jan 2, 2025 | Consulting Fee | $135 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 14 industry-funded studies in 2025, from 8 companies. The companies reported $171,207 in research payments for these studies, mostly to the institutions running them.
- A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After …
Novartis Pharmaceuticals Corporation - (ENHANCE) Evaluating the maintenance of efficacy when transitioning from current anti-CD20 therapy to ublituximab
Tg Therapeutics, Inc. - An Open label Single Arm Multi center Extension Study Evaluating Long term Safety Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis
Novartis Pharmaceuticals Corporation - Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Genzyme Corporation · Active, not recruiting · NCT06141473 - Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment
Roche Products Limited - Effectiveness of Switching to Cladribine Tablets in Multiple Sclerosis Patients with High Disease Activity or Disease Breakthrough in a US Real-World Population (HDA Switch Study)
EMD Serono, Inc. - Phase 3 multicenter randomized doubleblind group sequential placebocontrolled study to assess efficacy and safety of rimegepant for the treatment of migraine with or without aura in children and adolescents 6 to 18 …
Pfizer Inc. - A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Eli Lilly and Company · Active, not recruiting · NCT05026866 - Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie Inc. - A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
AbbVie Inc. · Recruiting · NCT05711394
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.